PWRM, CRWE, VNDA, COWN, RFMD- Stock Reports! from Stock-PR.com

Power3 Medical Products, Inc. (PWRM.OB)

Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, to name a few.

In addition, Power3 is a party to several litigation matters, most of which relate to various toxic debt instruments that were entered into by Power3 several years ago when it operated under the tenure of Chairman and CEO, Steven B. Rash. Because current management believes these toxic debt instruments are responsible for Power3’s depressed stock price and have distracted the company from its mission, Power3 plans to settle as many of these nagging lawsuits as possible prior to the completion of its merger with Rozetta-Cell Life Sciences, Inc. As for those lawsuits that cannot be speedily resolved, Power3 will continue to rigorously defend its position. For example, one such lawsuit involves Neogenomics, Inc., which was recently granted a motion for summary judgment with respect to an amount due under a convertible debenture. Power3 intends to appeal this decision.

Crown Equity Holdings Inc. (CRWE.OB) announcesd that it has extended its CRWENEWSWIRE global platform web presence and is now publishing online news and information to the following countries: Argentina, Australia, Brazil, Canada, China, France, Germany, India, Ireland, Italy, Japan, Malaysia, Mexico, New Zealand, Russia, Singapore, South Africa, South Korea, Spain, Taiwan, United Arab Emirates and the United Kingdom, using their specific country code domain and native language.

The company has also established over 1,100 city specific sites within the US, allowing Crown Equity Holdings Inc. to publish its news and information globally or geographically.

Crown Equity Holdings Inc., together with its digital network, currently provides electronic media services specializing in online publishing, which brings together targeted audiences and advertisers. Crown Equity Holdings Inc. offers internet media-driven advertising services, which covers and connects a range of marketing specialties, as well as search engine optimization for clients interested in online media awareness.

Crown Equity has the creative resources to dramatically enhance your company’s corporate identity with its in-house advertising and name-branding services. This includes creating, designing, implementing logos, and other strategies which rapidly increase your company’s credibility and value. As many people know, brand strength is a good indicator of the strength of a company and its financial value.

For more information about CRWE, visit:www.crownequityholdings.com

Vanda Pharmaceuticals, Inc. (Nasdaq:VNDA) announced that the European Commission (EC) has granted orphan drug designation for tasimelteon, an oral dual melatonin receptor agonist in Phase III clinical trails for Non-24-Hour Sleep/Wake Disorder (N24HSWD) in blind individuals with no light perception. This follows the positive opinion on the designation that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency adopted previously in the November 2010 COMP Committee Meeting.
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of clinical-stage products for various central nervous system disorders.

Cowen Group, Inc. (Nasdaq:COWN) announced that Edward Nash has joined the firm as Director and Senior Research Analyst. Based in New York, Mr. Nash will cover biotechnology in the health care sector of Cowen’s Research group and report to Barry Tarasoff, Cowen’s Director of Research.
Cowen Group, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides alternative investment management, investment banking, research, and sales and trading services for its clients.

RF Micro Devices Inc. (Nasdaq:RFMD) announced the expansion of its industry-leading 5GHz WiFi product portfolio to include three new 5GHz high-band WiFi front end modules (FEMs) with integrated power amplifiers (PAs). The three new 5GHz FEMs — the RF5686, the RF5506, and the RF5516 — deliver industry-leading high power and high linearity and are optimized for the rapidly growing smartphone and tablet markets.
RF Micro Devices, Inc. designs and manufactures radio frequency components and compound semiconductors in the United States and internationally.

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Sign Up For Free Stock Alerts At http://stock-pr.com/signup

________________________________________

Be Sure To Visit stock-pr.ning.com

**********************************************************************

The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.

Keywords: , amyotrophic, BC-SeraPro, biotechnology, Cowen, Helen Park, Ira Goldknopf, memantine hci, NASDAQ:COWN, Nasdaq:RFMD, Nasdaq:VNDA, Novartis, NuroPro, otc:PWRM, power3 medical, PWRM.OB, RF Micro Devices, Vanda